Jpmorgan Chase & CO Zai Lab LTD Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Zai Lab LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 45,455 shares of ZLAB stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,455
Previous 161,635 71.88%
Holding current value
$1.56 Million
Previous $4.23 Million 61.21%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$24.29 - $38.35 $2.82 Million - $4.46 Million
-116,180 Reduced 71.88%
45,455 $1.64 Million
Q4 2024

Feb 12, 2025
BUY
$24.61 - $33.18 $578,581 - $780,061
23,510 Added 17.02%
161,635 $4.23 Million
Q3 2024

Dec 26, 2024
SELL
$16.25 - $24.14 $1.73 Million - $2.57 Million
-106,397 Reduced 43.51%
138,125 $3.33 Million
Q3 2024

Nov 08, 2024
SELL
$16.25 - $24.14 $1.73 Million - $2.57 Million
-106,397 Reduced 43.51%
138,125 $3.33 Million
Q2 2024

Dec 26, 2024
BUY
$13.72 - $21.55 $1.46 Million - $2.29 Million
106,397 Added 77.03%
244,522 $4.24 Million
Q2 2024

Aug 12, 2024
BUY
$13.72 - $21.55 $2.75 Million - $4.32 Million
200,600 Added 456.72%
244,522 $4.24 Million
Q1 2024

Dec 26, 2024
SELL
$15.95 - $26.8 $1.5 Million - $2.52 Million
-94,203 Reduced 68.2%
43,922 $703,000
Q1 2024

May 10, 2024
BUY
$15.95 - $26.8 $48,456 - $81,418
3,038 Added 7.43%
43,922 $703,000
Q4 2023

Dec 26, 2024
SELL
$22.97 - $30.58 $2.23 Million - $2.97 Million
-97,241 Reduced 70.4%
40,884 $1.12 Million
Q4 2023

Feb 12, 2024
SELL
$22.97 - $30.58 $4.44 Million - $5.91 Million
-193,402 Reduced 82.55%
40,884 $1.12 Million
Q3 2023

Nov 14, 2023
BUY
$22.72 - $31.49 $915,275 - $1.27 Million
40,285 Added 20.77%
234,286 $5.7 Million
Q2 2023

Aug 11, 2023
SELL
$25.3 - $39.67 $2.31 Million - $3.63 Million
-91,489 Reduced 32.05%
194,001 $5.38 Million
Q1 2023

May 11, 2023
BUY
$30.21 - $48.1 $5.86 Million - $9.33 Million
194,063 Added 212.26%
285,490 $9.5 Million
Q4 2022

Feb 13, 2023
SELL
$22.28 - $38.71 $2.49 Million - $4.33 Million
-111,745 Reduced 55.0%
91,427 $2.81 Million
Q3 2022

Nov 14, 2022
SELL
$34.2 - $51.69 $1.25 Million - $1.89 Million
-36,638 Reduced 15.28%
203,172 $6.95 Million
Q2 2022

Aug 11, 2022
SELL
$23.14 - $49.68 $1.18 Million - $2.53 Million
-50,939 Reduced 17.52%
239,810 $8.32 Million
Q1 2022

May 11, 2022
SELL
$27.77 - $64.4 $3.62 Million - $8.39 Million
-130,221 Reduced 30.93%
290,749 $12.8 Million
Q4 2021

Feb 10, 2022
SELL
$54.9 - $105.21 $2.24 Million - $4.3 Million
-40,835 Reduced 8.84%
420,970 $26.5 Million
Q3 2021

Nov 12, 2021
BUY
$105.0 - $178.37 $48.5 Million - $82.4 Million
461,805 New
461,805 $48.7 Million

Others Institutions Holding ZLAB

# of Institutions
170
Shares Held
38.6M
Call Options Held
150K
Put Options Held
201K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.36B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email